AAAAAA

   
Results: 1-22 |
Results: 22
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
Authors: Foudraine, NA Jurriaans, S Weverling, GJ Burger, DM Hoetelmans, RMW Roos, MTL Maas, J Miedema, F Reiss, P Portegies, P de Wolf, F Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology
Authors: Alioum, A Dabis, F Dequae-Merchadou, L Haverkamp, G Hudgens, M Hughes, J Karon, J Leroy, V Newell, ML Richardson, B Weverling, GJ
Citation: A. Alioum et al., Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology, STAT MED, 20(23), 2001, pp. 3539-3556
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
Authors: Veldkamp, AI Weverling, GJ Lange, JMA Montaner, JSG Reiss, P Cooper, DA Vella, S Hall, D Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals, AIDS, 15(9), 2001, pp. 1089-1095
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection
Authors: van der Valk, M Gisolf, EH Reiss, P Wit, FWNM Japour, A Weverling, GJ Danner, SA
Citation: M. Van Der Valk et al., Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection, AIDS, 15(7), 2001, pp. 847-855
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection
Authors: Dukers, NHTM Goudsmit, J de Wit, JBF Prins, M Weverling, GJ Coutinho, RA
Citation: Nhtm. Dukers et al., Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection, AIDS, 15(3), 2001, pp. 369-378
Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex
Authors: Renwick, N Weverling, GJ Halaby, T Portegies, P Bakker, M Schulz, TF Goudsmit, J
Citation: N. Renwick et al., Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex, AIDS, 15(16), 2001, pp. 2165-2169
The ADAM study continued: maintenance therapy after 50 weeks of induction therapy
Authors: Reijers, MHE Weverling, GJ Jurriaans, S Roos, MTL Wit, FWNM Weigel, HM Ten Kate, RW Mulder, JW Richter, C Ter Hofstede, HJM Sprenger, H Hoetelmans, RMW Schuitemaker, H Lange, JMA
Citation: Mhe. Reijers et al., The ADAM study continued: maintenance therapy after 50 weeks of induction therapy, AIDS, 15(1), 2001, pp. 129-131
Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons
Authors: Renwick, N Weverling, GJ Schulz, T Goudsmit, J
Citation: N. Renwick et al., Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons, J INFEC DIS, 183(9), 2001, pp. 1427-1427
Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine
Authors: Gisolf, EH Dreezen, C Danner, SA Weel, JLF Weverling, GJ
Citation: Eh. Gisolf et al., Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine, CLIN INF D, 31(5), 2000, pp. 1234-1239
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
Authors: van Praag, RME Weverling, GJ Portegies, P Jurriaans, S Zhou, XJ Turner-Foisy, ML Sommadossi, JP Burger, DM Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir, AIDS, 14(9), 2000, pp. 1187-1194
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
Authors: den Brinker, M Wit, FWNM Wertheim-van Dillen, PME Jurriaans, S Weel, J van Leeuwen, R Pakker, NG Reiss, P Danner, SA Weverling, GJ Lange, JMA
Citation: M. Den Brinker et al., Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection, AIDS, 14(18), 2000, pp. 2895-2902
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients
Authors: Ruxrungtham, K Kroon, EDMB Ungsedhapand, C Teeratakulpisarn, S Ubolyam, S Buranapraditkun, S van Leeuwen, R Weverling, GJ Kunanusont, C Lange, JMA Cooper, DA Phanuphak, P
Citation: K. Ruxrungtham et al., A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients, AIDS, 14(10), 2000, pp. 1375-1382
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study
Authors: Reijers, MHE Weigel, HM Hart, AAM Ten Kate, RW Mulder, JW Reiss, P Schuitemaker, H Hoetelmans, RMW Weverling, GJ Lange, JMA
Citation: Mhe. Reijers et al., Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study, AIDS, 14(1), 2000, pp. 59-68
Cerebrospinal fluid beta 2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine
Authors: Enting, RH Foudraine, NA Lange, JMA Jurriaans, S van der Poll, T Weverling, GJ Portegies, P
Citation: Rh. Enting et al., Cerebrospinal fluid beta 2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine, J NEUROIMM, 102(2), 2000, pp. 216-221
Value of different assays for detection of human cytomegalovirus (HCMV) inpredicting the development of HCMV disease in human immunodeficiency virus-infected patients
Authors: Blank, BSN Meenhorst, PL Mulder, JW Weverling, GJ Putter, H Pauw, W van Dijk, WC Smits, P Lie-A-Ling, S Reiss, P Lange, JMA
Citation: Bsn. Blank et al., Value of different assays for detection of human cytomegalovirus (HCMV) inpredicting the development of HCMV disease in human immunodeficiency virus-infected patients, J CLIN MICR, 38(2), 2000, pp. 563-569
Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): Analysis of seroconversions to ORF65 and ORF73
Authors: Goudsmit, J Renwick, N Dukers, NHTM Coutinho, RA Heisterkamp, S Bakker, M Schulz, TF Cornelissen, M Weverling, GJ
Citation: J. Goudsmit et al., Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): Analysis of seroconversions to ORF65 and ORF73, P NAS US, 97(9), 2000, pp. 4838-4843
Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis
Authors: Simpson, AJH Smith, MD Weverling, GJ Suputtamongkol, Y Angus, BJ Chaowagul, W White, NJ van Deventer, SJH Prins, JM
Citation: Ajh. Simpson et al., Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis, J INFEC DIS, 181(2), 2000, pp. 621-625
Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men
Authors: Dukers, NHTM Renwick, N Prins, M Geskus, RB Schulz, TF Weverling, GJ Coutinho, RA Goudsmit, J
Citation: Nhtm. Dukers et al., Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men, AM J EPIDEM, 151(3), 2000, pp. 213-224
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients
Authors: Blank, BSN Meenhorst, PL Weverling, GJ Stout-Zonneveld, AAM Pauw, W Mulder, JW van Dijk, WC Smits, P Lange, JMA
Citation: Bsn. Blank et al., Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients, AIDS, 13(18), 1999, pp. 2533-2539
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
Authors: Weverling, GJ Mocroft, A Ledergerber, B Kirk, O Gonzalez-Lahoz, J Monforte, AD Proenca, R Phillips, AN Lundgren, JD Reiss, P
Citation: Gj. Weverling et al., Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection, LANCET, 353(9161), 1999, pp. 1293-1298
Outcome and predictors of failure of highly active antiretroviral therapy:One-year follow-up of a cohort of human immunodeficiency virus type 1 infected persons
Authors: Wit, FWNM van Leeuwen, R Weverling, GJ Jurriaans, S Nauta, K Steingrover, R Schuijtemaker, J Eyssen, X Fortuin, D Weeda, M de Wolf, F Reiss, P Danner, SA Lange, JMA
Citation: Fwnm. Wit et al., Outcome and predictors of failure of highly active antiretroviral therapy:One-year follow-up of a cohort of human immunodeficiency virus type 1 infected persons, J INFEC DIS, 179(4), 1999, pp. 790-798
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma
Authors: Renwick, N Halaby, T Weverling, GJ Dukers, NHTM Simpson, GR Coutinho, RA Lange, JMA Schulz, TF Goudsmit, J
Citation: N. Renwick et al., Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma, AIDS, 12(18), 1998, pp. 2481-2488
Risultati: 1-22 |